22 results on '"Bradwell, Arthur R."'
Search Results
2. Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
3. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
4. Serum Heavy/Light Chain and Free Light Chain Measurements Provide Prognostic Information, Allow Creation of a Prognostic Model and Identify Clonal Changes (clonal tiding) Through the Course of Multiple Myeloma (MM)
5. Acquired Hemophilia Associated with Smoldering Myeloma: Demonstration That the Monoclonal Gammopathy Acts as the Factor VIII Inhibitor.
6. Abnormal Serum Free Light Chain Ratios Are Associated with Earlier Time to First Treatment and Poor Survival in Patients with Chronic Lymphocytic Leukaemia
7. Immunoassays for IgG and IgA Light Chain Pairs Are More Sensitive Than Immunofixation Electrophoresis in Multiple Myeloma and Provide Quantitative Analysis
8. Monoclonal Gammopathy as a Determinant of Adverse Outcomes in Patients with Chronic Kidney Disease.
9. Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis in Multiple Myeloma: In-Vitro and In-Vivo Studies.
10. Renal Recovery Following Light Chain Removal by Extended Haemodialysis in a Patient with Cast Nephropathy.
11. Rapid Removal of Free Light Chains from Serum by Hemodialysis for Patients with Myeloma Kidney.
12. Clinical Profile and Treatment Outcome in 92 Patients with AL Amyloidosis Associated with IgM Paraproteinaemia.
13. Standard Oral Melphalan Chemotherapy for AL Amyloidosis Revisited Using the Serum Free Light Chain Assay.
14. Efficacy of Risk Adapted Cyclophosphamide, Thalidomide and Dexamethasone in Systemic AL Amyloidosis.
15. Serum Free Kappa to Free Lambda Ratios as an Adjunct to Serum Protein Electrophoresis for the Detection of Monoclonal Proteins in the Serum.
16. Presence of an Abnormal Serum Free Light Ratio Is an Independent Risk Factor for Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS).
17. Serum Free Light Chain Levels in Asymptomatic Myeloma.
18. Correlation of Serum Free Light Chains and Bone Marrow Plasma Cell Infiltration in Multiple Myeloma.
19. Influence of plasma immunoglobulin level on antibody synthesis
20. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
21. Intermediate Dose Intravenous Melphalan and Dexamethasone Treatment in 144 Patients with Systemic AL Amyloidosis.
22. Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis in Multiple Myeloma: In-Vitroand In-VivoStudies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.